2 completed, 1 recruiting, 1 withdrawn. 4 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 1, Withdrawn 1 |
Follow Synthroid: new trials by email Literature Review of Synthroid trials Research Report on Synthroid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans Synthroid, Placebo - Nonalcoholic Steatohepatitis, Liver Fibrosis | Phase 2 | Recruiting | VA Office of Research and Development | 128 | 2023-04-01 | 2026-02-19 |
| Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery Levothyroxine, Placebo - Hypothyroidism, Neoplasms | Phase 2 / Phase 3 | Withdrawn | University of Alberta | 2015-07-01 | 2022-07-13 | |
| Sunitinib or Cediranib for Alveolar Soft Part Sarcoma Cediranib, Sunitinib, Prochlorperazine - Sarcoma, Alveolar Soft Part | Phase 2 | Completed | National Cancer Institute (NCI) | 34 | 2011-07-18 | 2026-02-02 |
| Subclinical Hypothyroidism and Mind in the Elderly levothyroxine sodium, excipient without levothyroxine (placebo) - Subclinical Hypothyroidism | Phase 2 / Phase 3 | Completed | Universidad Autonoma de Nuevo Leon | 70 | 2009-06-01 | 2012-06-28 |
Cognitive Dysfunction (1) · Hypothyroidism (1) · Liver Cirrhosis (1) · Neoplasms (1) · Non-alcoholic Fatty Liver Disease (1) · Postoperative Complications (1) · Sarcoma, Alveolar Soft Part (1)
National Cancer Institute (NCI) (1) · Universidad Autonoma de Nuevo Leon (1) · University of Alberta (1) · VA Office of Research and Development (1)
United States (2) · Mexico (1)
Alice P Chen, M.D. (1) · Jamal A Ibdah, MD PhD (1) · Jesus Z Villarreal-Perez, M.D. (1) · Lilia Cardenas-Ibarra, M.D. (1)
I01CX002436 (1)